-
Je něco špatně v tomto záznamu ?
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study
S. Groeneweg, FS. van Geest, A. Abacı, A. Alcantud, GP. Ambegaonkar, CM. Armour, P. Bakhtiani, D. Barca, ES. Bertini, IM. van Beynum, N. Brunetti-Pierri, M. Bugiani, M. Cappa, G. Cappuccio, B. Castellotti, C. Castiglioni, K. Chatterjee, IFM. de...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
- MeSH
- biologické markery analýza MeSH
- dítě MeSH
- dospělí MeSH
- duševní poruchy etiologie patologie MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mezinárodní agentury MeSH
- míra přežití MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace MeSH
- následné studie MeSH
- nemoci svalů etiologie patologie MeSH
- neurovývojové poruchy etiologie patologie MeSH
- předškolní dítě MeSH
- přenašeče monokarboxylových kyselin nedostatek genetika MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- senioři MeSH
- symportéry nedostatek genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
BACKGROUND: Disordered thyroid hormone transport, due to mutations in the SLC16A2 gene encoding monocarboxylate transporter 8 (MCT8), is characterised by intellectual and motor disability resulting from cerebral hypothyroidism and chronic peripheral thyrotoxicosis. We sought to systematically assess the phenotypic characteristics and natural history of patients with MCT8 deficiency. METHODS: We did an international, multicentre, cohort study, analysing retrospective data from Jan 1, 2003, to Dec 31, 2019, from patients with MCT8 deficiency followed up in 47 hospitals in 22 countries globally. The key inclusion criterion was genetically confirmed MCT8 deficiency. There were no exclusion criteria. Our primary objective was to analyse the overall survival of patients with MCT8 deficiency and document causes of death. We also compared survival between patients who did or did not attain full head control by age 1·5 years and between patients who were or were not underweight by age 1-3 years (defined as a bodyweight-for-age Z score <-2 SDs or <5th percentile according to WHO definition). Other objectives were to assess neurocognitive function and outcomes, and clinical parameters including anthropometric characteristics, biochemical markers, and neuroimaging findings. FINDINGS: Between Oct 14, 2014, and Jan 17, 2020, we enrolled 151 patients with 73 different MCT8 (SLC16A2) mutations. Median age at diagnosis was 24·0 months (IQR 12·0-60·0, range 0·0-744·0). 32 (21%) of 151 patients died; the main causes of mortality in these patients were pulmonary infection (six [19%]) and sudden death (six [19%]). Median overall survival was 35·0 years (95% CI 8·3-61·7). Individuals who did not attain head control by age 1·5 years had an increased risk of death compared with patients who did attain head control (hazard ratio [HR] 3·46, 95% CI 1·76-8·34; log-rank test p=0·0041). Patients who were underweight during age 1-3 years had an increased risk for death compared with patients who were of normal bodyweight at this age (HR 4·71, 95% CI 1·26-17·58, p=0·021). The few motor and cognitive abilities of patients did not improve with age, as evidenced by the absence of significant correlations between biological age and scores on the Gross Motor Function Measure-88 and Bayley Scales of Infant Development III. Tri-iodothyronine concentrations were above the age-specific upper limit in 96 (95%) of 101 patients and free thyroxine concentrations were below the age-specific lower limit in 94 (89%) of 106 patients. 59 (71%) of 83 patients were underweight. 25 (53%) of 47 patients had elevated systolic blood pressure above the 90th percentile, 34 (76%) of 45 patients had premature atrial contractions, and 20 (31%) of 64 had resting tachycardia. The most consistent MRI finding was a global delay in myelination, which occurred in 13 (100%) of 13 patients. INTERPRETATION: Our description of characteristics of MCT8 deficiency in a large patient cohort reveals poor survival with a high prevalence of treatable underlying risk factors, and provides knowledge that might inform clinical management and future evaluation of therapies. FUNDING: Netherlands Organisation for Health Research and Development, and the Sherman Foundation.
Centre for Endocrinology William Harvey Research institute Queen Mary University London London UK
Child Neurology Unit Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
Departamento de Neurologia Pediatrica Clinica Las Condes Santiago Chile
Department of Cardiology and Intensive Care Medicine Erasmus Medical Centre Rotterdam Netherlands
Department of Chemical Pathology Mater Pathology South Brisbane QLD Australia
Department of Diabetes and Endocrinology Women's and Children's Hospital North Adelaide SA Australia
Department of Endocrinology and Diabetes Queensland Children's Hospital South Brisbane QLD Australia
Department of Endocrinology St John's Medical College Hospital Bengaluru Karnataka India
Department of Neuropediatrics University Children's Hospital Zurich Zürich Switzerland
Department of Paediatric Neurology Erasmus Medical Centre Rotterdam Netherlands
Department of Paediatrics Christian Medical College Vellore India
Department of Paediatrics Semmelweis University Budapest Hungary
Department of Pediatric Endocrinology and Diabetology University Hospital Angers France
Department of Pediatrics Clinica Las Condes Santiago Chile
Department of Translational Medicine Federico 2 University Naples Italy
Dept of Paediatric Endocrinology Barts Health NHS Trust London UK
Division of Endocrinology Bambino Gesu' Children's Research Hospital IRCCS Rome Italy
Division of Paediatric Radiology Erasmus Medical Centre Rotterdam Netherlands
Division of Pediatric Endocrinology Faculty of Medicine Dokuz Eylul University İzmir Turkey
Faculdade de Medicina Centro Universitario Estácio de Ribeirão Preto Ribeirão Preto Brazil
Faculty of Medicine University of Queensland Brisbane QLD Australia
Genomics Institute Mary Bridge Children's Hospital MultiCare Health System Tacoma WA USA
Hebrew University of Jerusalem Jerusalem Israel
Institute of Maternal and Child Research University of Chile Santiago Chile
John Hunter Children's Hospital and University of Newcastle Newcastle NSW Australia
KUNO Children's University Hospital Campus St Hedwig University of Regensburg Regensburg Germany
Lancashire Teaching Hospitals NHS Trust Lancashire UK
Marmara University School of Medicine Department of Pediatric Endocrinology Istanbul Turkey
Medanta Superspeciality Hospital Indore India
Medical Genetics Service Hospital de Clínicas de Porto Alegre Porto Alegre Brazil
Paediatric Endocrinology Unit Kaplan Medical Center Rehovot Israel
Paediatric Neurology Clinic Alexandru Obregia Hospital Bucharest Romania
Panorama Medical Centre Cape Town South Africa
Pediatric Endocrinology Group Santa Catarina Hospital São Paulo Brazil
Pediatric Neurology Section Hospital Francesc de Borja de Gandia Valencia Spain
Plymouth Hospitals NHS Trust Plymouth UK
Royal Children's Hospital Parkville Melbourne VIC Australia
Teaching Hospital of Universidade Federal de Pelotas Pelotas Brazil
Telethon Institute of Genetics and Medicine Pozzuoli Naples Italy
Università Vita Salute San Raffaele Milan Italy
University of Debrecen Pediatric Institute Debrecen Hungary
University of Lille Lille France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024929
- 003
- CZ-PrNML
- 005
- 20201222153619.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S2213-8587(20)30153-4 $2 doi
- 035 __
- $a (PubMed)32559475
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Groeneweg, Stefan $u Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
- 245 10
- $a Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study / $c S. Groeneweg, FS. van Geest, A. Abacı, A. Alcantud, GP. Ambegaonkar, CM. Armour, P. Bakhtiani, D. Barca, ES. Bertini, IM. van Beynum, N. Brunetti-Pierri, M. Bugiani, M. Cappa, G. Cappuccio, B. Castellotti, C. Castiglioni, K. Chatterjee, IFM. de Coo, R. Coutant, D. Craiu, P. Crock, C. DeGoede, K. Demir, A. Dica, P. Dimitri, A. Dolcetta-Capuzzo, MHG. Dremmen, R. Dubey, A. Enderli, J. Fairchild, J. Gallichan, B. George, EF. Gevers, A. Hackenberg, Z. Halász, B. Heinrich, T. Huynh, A. Kłosowska, MS. van der Knaap, MM. van der Knoop, D. Konrad, DA. Koolen, H. Krude, A. Lawson-Yuen, J. Lebl, M. Linder-Lucht, CF. Lorea, CM. Lourenço, RJ. Lunsing, G. Lyons, J. Malikova, EE. Mancilla, A. McGowan, V. Mericq, FM. Lora, C. Moran, KE. Müller, I. Oliver-Petit, L. Paone, PG. Paul, M. Polak, F. Porta, FO. Poswar, C. Reinauer, K. Rozenkova, TS. Menevse, P. Simm, A. Simon, Y. Singh, M. Spada, J. van der Spek, MAM. Stals, A. Stoupa, GM. Subramanian, D. Tonduti, S. Turan, CA. den Uil, J. Vanderniet, A. van der Walt, JL. Wémeau, J. Wierzba, MY. de Wit, NI. Wolf, M. Wurm, F. Zibordi, A. Zung, N. Zwaveling-Soonawala, WE. Visser,
- 520 9_
- $a BACKGROUND: Disordered thyroid hormone transport, due to mutations in the SLC16A2 gene encoding monocarboxylate transporter 8 (MCT8), is characterised by intellectual and motor disability resulting from cerebral hypothyroidism and chronic peripheral thyrotoxicosis. We sought to systematically assess the phenotypic characteristics and natural history of patients with MCT8 deficiency. METHODS: We did an international, multicentre, cohort study, analysing retrospective data from Jan 1, 2003, to Dec 31, 2019, from patients with MCT8 deficiency followed up in 47 hospitals in 22 countries globally. The key inclusion criterion was genetically confirmed MCT8 deficiency. There were no exclusion criteria. Our primary objective was to analyse the overall survival of patients with MCT8 deficiency and document causes of death. We also compared survival between patients who did or did not attain full head control by age 1·5 years and between patients who were or were not underweight by age 1-3 years (defined as a bodyweight-for-age Z score <-2 SDs or <5th percentile according to WHO definition). Other objectives were to assess neurocognitive function and outcomes, and clinical parameters including anthropometric characteristics, biochemical markers, and neuroimaging findings. FINDINGS: Between Oct 14, 2014, and Jan 17, 2020, we enrolled 151 patients with 73 different MCT8 (SLC16A2) mutations. Median age at diagnosis was 24·0 months (IQR 12·0-60·0, range 0·0-744·0). 32 (21%) of 151 patients died; the main causes of mortality in these patients were pulmonary infection (six [19%]) and sudden death (six [19%]). Median overall survival was 35·0 years (95% CI 8·3-61·7). Individuals who did not attain head control by age 1·5 years had an increased risk of death compared with patients who did attain head control (hazard ratio [HR] 3·46, 95% CI 1·76-8·34; log-rank test p=0·0041). Patients who were underweight during age 1-3 years had an increased risk for death compared with patients who were of normal bodyweight at this age (HR 4·71, 95% CI 1·26-17·58, p=0·021). The few motor and cognitive abilities of patients did not improve with age, as evidenced by the absence of significant correlations between biological age and scores on the Gross Motor Function Measure-88 and Bayley Scales of Infant Development III. Tri-iodothyronine concentrations were above the age-specific upper limit in 96 (95%) of 101 patients and free thyroxine concentrations were below the age-specific lower limit in 94 (89%) of 106 patients. 59 (71%) of 83 patients were underweight. 25 (53%) of 47 patients had elevated systolic blood pressure above the 90th percentile, 34 (76%) of 45 patients had premature atrial contractions, and 20 (31%) of 64 had resting tachycardia. The most consistent MRI finding was a global delay in myelination, which occurred in 13 (100%) of 13 patients. INTERPRETATION: Our description of characteristics of MCT8 deficiency in a large patient cohort reveals poor survival with a high prevalence of treatable underlying risk factors, and provides knowledge that might inform clinical management and future evaluation of therapies. FUNDING: Netherlands Organisation for Health Research and Development, and the Sherman Foundation.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mezinárodní agentury $7 D007390
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a duševní poruchy $x etiologie $x patologie $7 D001523
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a přenašeče monokarboxylových kyselin $x nedostatek $x genetika $7 D027501
- 650 _2
- $a nemoci svalů $x etiologie $x patologie $7 D009135
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a neurovývojové poruchy $x etiologie $x patologie $7 D065886
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a symportéry $x nedostatek $x genetika $7 D027981
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a van Geest, Ferdy S $u Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
- 700 1_
- $a Abacı, Ayhan $u Division of Pediatric Endocrinology, Faculty of Medicine, Dokuz Eylul University, İzmir, Turkey.
- 700 1_
- $a Alcantud, Alberto $u Pediatric Neurology Section, Hospital Francesc de Borja de Gandia, Valencia, Spain.
- 700 1_
- $a Ambegaonkar, Gautem P $u Department of Paediatric Neurology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- 700 1_
- $a Armour, Christine M $u Regional Genetics Program, Children's Hospital of Eastern Ontario, and Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
- 700 1_
- $a Bakhtiani, Priyanka $u University of Louisville, Louisville, KY, USA.
- 700 1_
- $a Barca, Diana $u Paediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania; Department of Neurosciences, Paediatric Neurology Discipline II, Carol Davila University of Medicine, Bucharest, Romania.
- 700 1_
- $a Bertini, Enrico S $u Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital IRCCS, Rome, Italy.
- 700 1_
- $a van Beynum, Ingrid M $u Sophia Children's Hospital, Division of Paediatric Cardiology, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Brunetti-Pierri, Nicola $u Department of Translational Medicine, Federico II University, Naples, Italy; Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, Italy.
- 700 1_
- $a Bugiani, Marianna $u Department of Child Neurology, Center for Childhood White Matter Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, and Amsterdam Neuroscience, Amsterdam, Netherlands; Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
- 700 1_
- $a Cappa, Marco $u Division of Endocrinology, Bambino Gesu' Children's Research Hospital IRCCS, Rome, Italy.
- 700 1_
- $a Cappuccio, Gerarda $u Department of Translational Medicine, Federico II University, Naples, Italy; Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, Italy.
- 700 1_
- $a Castellotti, Barbara $u Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
- 700 1_
- $a Castiglioni, Claudia $u Departamento de Neurologia Pediatrica, Clinica Las Condes, Santiago, Chile.
- 700 1_
- $a Chatterjee, Krishna $u Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 700 1_
- $a de Coo, Irenaeus F M $u Department of Paediatric Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Coutant, Régis $u Department of Pediatric Endocrinology and Diabetology, University Hospital, Angers, France.
- 700 1_
- $a Craiu, Dana $u Paediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania; Department of Neurosciences, Paediatric Neurology Discipline II, Carol Davila University of Medicine, Bucharest, Romania.
- 700 1_
- $a Crock, Patricia $u John Hunter Children's Hospital and University of Newcastle, Newcastle, NSW, Australia.
- 700 1_
- $a DeGoede, Christian $u Lancashire Teaching Hospitals NHS Trust, Lancashire, UK.
- 700 1_
- $a Demir, Korcan $u Division of Pediatric Endocrinology, Faculty of Medicine, Dokuz Eylul University, İzmir, Turkey.
- 700 1_
- $a Dica, Alice $u Paediatric Neurology Clinic, Alexandru Obregia Hospital, Bucharest, Romania; Department of Neurosciences, Paediatric Neurology Discipline II, Carol Davila University of Medicine, Bucharest, Romania.
- 700 1_
- $a Dimitri, Paul $u Sheffield Children's NHS Foundation Trust, Sheffield Hallam University and University of Sheffield, Sheffield, UK.
- 700 1_
- $a Dolcetta-Capuzzo, Anna $u Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands; Università Vita-Salute San Raffaele, Milan, Italy.
- 700 1_
- $a Dremmen, Marjolein H G $u Division of Paediatric Radiology, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Dubey, Rachana $u Medanta Superspeciality Hospital, Indore, India.
- 700 1_
- $a Enderli, Anina $u Department of Neuropediatrics, University Children's Hospital Zurich, Zürich, Switzerland.
- 700 1_
- $a Fairchild, Jan $u Department of Diabetes and Endocrinology, Women's and Children's Hospital, North Adelaide, SA, Australia.
- 700 1_
- $a Gallichan, Jonathan $u Plymouth Hospitals NHS Trust, Plymouth, UK.
- 700 1_
- $a George, Belinda $u Department of Endocrinology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.
- 700 1_
- $a Gevers, Evelien F $u Centre for Endocrinology, William Harvey Research institute, Queen Mary University London, London, UK; Dept of Paediatric Endocrinology, Barts Health NHS Trust, London, UK.
- 700 1_
- $a Hackenberg, Annette $u Department of Neuropediatrics, University Children's Hospital Zurich, Zürich, Switzerland.
- 700 1_
- $a Halász, Zita $u Department of Paediatrics, Semmelweis University, Budapest, Hungary.
- 700 1_
- $a Heinrich, Bianka $u Department of Neuropediatrics, University Children's Hospital Zurich, Zürich, Switzerland.
- 700 1_
- $a Huynh, Tony $u Department of Endocrinology & Diabetes, Queensland Children's Hospital, South Brisbane, QLD, Australia; Department of Chemical Pathology, Mater Pathology, South Brisbane, QLD, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
- 700 1_
- $a Kłosowska, Anna $u Medical University of Gdańsk, Department of Paediatrics, Haematology & Oncology, Department of General Nursery, Gdańsk, Poland.
- 700 1_
- $a van der Knaap, Marjo S $u Department of Child Neurology, Center for Childhood White Matter Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, and Amsterdam Neuroscience, Amsterdam, Netherlands.
- 700 1_
- $a van der Knoop, Marieke M $u Department of Paediatric Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Konrad, Daniel $u Division of Pediatric Endocrinology and Diabetology and Children's Research Center, University Children's Hospital, Zurich, Switzerland.
- 700 1_
- $a Koolen, David A $u Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center (Radboudumc), Nijmegen, Netherlands.
- 700 1_
- $a Krude, Heiko $u Department of Paediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Lawson-Yuen, Amy $u Genomics Institute Mary Bridge Children's Hospital, MultiCare Health System Tacoma, WA, USA.
- 700 1_
- $a Lebl, Jan $u Department of Paediatrics, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Linder-Lucht, Michaela $u Division of Neuropediatrics and Muscular Disorders, Department of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany.
- 700 1_
- $a Lorea, Cláudia F $u Teaching Hospital of Universidade Federal de Pelotas, Pelotas, Brazil.
- 700 1_
- $a Lourenço, Charles M $u Faculdade de Medicina, Centro Universitario Estácio de Ribeirão Preto, Ribeirão Preto, Brazil.
- 700 1_
- $a Lunsing, Roelineke J $u Department of Child Neurology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
- 700 1_
- $a Lyons, Greta $u Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Malikova, Jana $u Department of Paediatrics, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Mancilla, Edna E $u Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, PA, USA.
- 700 1_
- $a McGowan, Anne $u Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Mericq, Veronica $u Institute of Maternal and Child Research, University of Chile, Santiago, Chile; Department of Pediatrics, Clinica Las Condes, Santiago, Chile.
- 700 1_
- $a Lora, Felipe M $u Pediatric Endocrinology Group, Santa Catarina Hospital, São Paulo, Brazil.
- 700 1_
- $a Moran, Carla $u Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Müller, Katalin E $u University of Debrecen, Pediatric Institute, Debrecen, Hungary.
- 700 1_
- $a Oliver-Petit, Isabelle $u Department of Paediatric Endocrinology and Genetics, Children's Hospital, Toulouse University Hospital, Toulouse, France.
- 700 1_
- $a Paone, Laura $u Division of Endocrinology, Bambino Gesu' Children's Research Hospital IRCCS, Rome, Italy.
- 700 1_
- $a Paul, Praveen G $u Department of Paediatrics, Christian Medical College, Vellore, India.
- 700 1_
- $a Polak, Michel $u Paediatric Endocrinology, Diabetology and Gynaecology Department, Necker Children's University Hospital, Imagine Institute, Paris, France.
- 700 1_
- $a Porta, Francesco $u Department of Paediatrics, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
- 700 1_
- $a Poswar, Fabiano O $u Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
- 700 1_
- $a Reinauer, Christina $u Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Duesseldorf, Germany.
- 700 1_
- $a Rozenkova, Klara $u Department of Paediatrics, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Menevse, Tuba S $u Marmara University School of Medicine Department of Pediatric Endocrinology, Istanbul, Turkey.
- 700 1_
- $a Simm, Peter $u Royal Children's Hospital, Parkville, Melbourne, VIC, Australia.
- 700 1_
- $a Simon, Anna $u Department of Paediatrics, Christian Medical College, Vellore, India.
- 700 1_
- $a Singh, Yogen $u Department of Paediatric Cardiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- 700 1_
- $a Spada, Marco $u Department of Paediatrics, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
- 700 1_
- $a van der Spek, Jet $u Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center (Radboudumc), Nijmegen, Netherlands.
- 700 1_
- $a Stals, Milou A M $u Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
- 700 1_
- $a Stoupa, Athanasia $u Paediatric Endocrinology, Diabetology and Gynaecology Department, Necker Children's University Hospital, Imagine Institute, Paris, France.
- 700 1_
- $a Subramanian, Gopinath M $u John Hunter Children's Hospital and University of Newcastle, Newcastle, NSW, Australia.
- 700 1_
- $a Tonduti, Davide $u Child Neurology Unit, Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy.
- 700 1_
- $a Turan, Serap $u Marmara University School of Medicine Department of Pediatric Endocrinology, Istanbul, Turkey.
- 700 1_
- $a den Uil, Corstiaan A $u Department of Cardiology and Intensive Care Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Vanderniet, Joel $u John Hunter Children's Hospital and University of Newcastle, Newcastle, NSW, Australia.
- 700 1_
- $a van der Walt, Adri $u Panorama Medical Centre, Cape Town, South Africa.
- 700 1_
- $a Wémeau, Jean-Louis $u University of Lille, Lille, France.
- 700 1_
- $a Wierzba, Jolante $u Medical University of Gdańsk, Department of Paediatrics, Haematology & Oncology, Department of General Nursery, Gdańsk, Poland.
- 700 1_
- $a de Wit, Marie-Claire Y $u Department of Paediatric Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
- 700 1_
- $a Wolf, Nicole I $u Department of Child Neurology, Center for Childhood White Matter Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, and Amsterdam Neuroscience, Amsterdam, Netherlands.
- 700 1_
- $a Wurm, Michael $u Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany; KUNO Children's University Hospital, Campus St. Hedwig, University of Regensburg, Regensburg, Germany.
- 700 1_
- $a Zibordi, Federica $u Child Neurology Unit, Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy.
- 700 1_
- $a Zung, Amnon $u Paediatric Endocrinology Unit, Kaplan Medical Center, Rehovot, Israel; Hebrew University of Jerusalem, Jerusalem, Israel.
- 700 1_
- $a Zwaveling-Soonawala, Nitash $u Emma Children's Hospital, Department of Paediatric Endocrinology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
- 700 1_
- $a Visser, W Edward $u Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands. Electronic address: w.e.visser@erasmusmc.nl.
- 773 0_
- $w MED00186388 $t The lancet. Diabetes & endocrinology $x 2213-8595 $g Roč. 8, č. 7 (2020), s. 594-605
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32559475 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153615 $b ABA008
- 999 __
- $a ok $b bmc $g 1599074 $s 1115615
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c 7 $d 594-605 $e - $i 2213-8595 $m The lancet. Diabetes & endocrinology $n Lancet Diabetes Endocrinol $x MED00186388
- LZP __
- $a Pubmed-20201125
